---
trial_id: 722
discovery_date: 2022-04-24 16:23:21.293784
date: 2022-04-24 16:23:21.293784
title: "A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for Participants With Relapsing-remitting Multiple Sclerosis Treated With Ozanimod (Zeposia®)"
summary: |
  <b>Condition</b>:    Multiple Sclerosis, Relapsing-Remitting<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Bristol-Myers Squibb<br /><b>Recruiting</b>
link: 'https://clinicaltrials.gov/ct2/show/NCT05335031?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14'
published_date: 2022-04-19 16:00:00
trial_source: ClinicalTrials.gov
relevant: 
options:
  unlisted: false
---
<b>Condition</b>:    Multiple Sclerosis, Relapsing-Remitting<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Bristol-Myers Squibb<br /><b>Recruiting</b>